You are currently viewing a new version of our website. To view the old version click .

Hematology Reports, Volume 16, Issue 2

June 2024 - 21 articles

Cover Story: Immune thrombocytopenia (ITP) is an autoimmune disease characterized by an isolated decrease in the platelet count and an increased risk of bleeding. The pathogenesis is complex, affecting multiple components of the immune system and causing both peripheral destruction of platelets and impaired central megakaryopoiesis and platelet production in the bone marrow. Here, we intend to contextualize the current knowledge on the pathophysiology, terminology, epidemiology, clinical manifestations, diagnosis, and prognosis of ITP from a historical perspective and the first references to the never-stopping garnering of knowledge about this entity. We highlight the necessity to better understand ITP in order to be able to provide ITP patients with personalized treatment options, improving disease prognosis and reducing the incidence or frequency of refractoriness. View this paper
  • Issues are regarded as officially published after their release is announced to the table of contents alert mailing list .
  • You may sign up for email alerts to receive table of contents of newly released issues.
  • PDF is the official format for papers published in both, html and pdf forms. To view the papers in pdf format, click on the "PDF Full-text" link, and use the free Adobe Reader to open them.

Articles (21)

  • Article
  • Open Access
1 Citations
2,420 Views
12 Pages

Treatment Patterns and Clinical Outcomes of Patients with Moderate to Severe Acute Graft-Versus-Host Disease: A Multicenter Chart Review Study

  • David Michonneau,
  • Raynier Devillier,
  • Mikko Keränen,
  • Marie Thérèse Rubio,
  • Malin Nicklasson,
  • Hélène Labussière-Wallet,
  • Martin Carre,
  • Anne Huynh,
  • Elisabet Viayna and
  • Montserrat Roset
  • + 7 authors

Acute graft-versus-host disease (aGVHD) remains a barrier to successful allogeneic hematopoietic stem cell transplantation (HSCT) outcomes. Contemporary comprehensive analyses of real-world clinical outcomes among patients who develop aGVHD post-HSCT...

  • Review
  • Open Access
7 Citations
3,303 Views
13 Pages

Current Therapeutic Sequencing in Chronic Lymphocytic Leukemia

  • Samir Mouhssine,
  • Nawar Maher,
  • Sreekar Kogila,
  • Claudio Cerchione,
  • Giovanni Martinelli and
  • Gianluca Gaidano

30 April 2024

The treatment landscape of chronic lymphocytic leukemia (CLL), the most frequent leukemia in adults, is constantly changing. CLL patients can be divided into three risk categories, based on their IGHV mutational status and the occurrence of TP53 disr...

  • Case Report
  • Open Access
2,059 Views
10 Pages

29 April 2024

Objectives: The aim of this review is to focus on the possibility of patients with squamous cell carcinoma to develop a second primary disease such as DLBCL, perhaps because of the irradiation of the head and neck area. Materials and methods: A case...

  • Case Report
  • Open Access
2,911 Views
5 Pages

Eculizumab Treatment of Massive Hemolysis Occurring in a Rare Co-Existence of Paroxysmal Nocturnal Hemoglobinuria and Myasthenia Gravis

  • Ráhel Réka Bicskó,
  • Árpád Illés,
  • Zsuzsanna Hevessy,
  • Gergely Ivády,
  • György Kerekes,
  • Gábor Méhes,
  • Tünde Csépány and
  • Lajos Gergely

19 April 2024

The co-occurrence of myasthenia gravis (MG) and paroxysmal nocturnal hemoglobinuria (PNH) is rare; only one case has been published so far. We report a 63-year-old Caucasian female patient who was diagnosed with MG at the age of 43. Thymoma was also...

  • Review
  • Open Access
38 Citations
7,921 Views
11 Pages

18 April 2024

Menin inhibitors are new and promising agents currently in clinical development that target the HOX/MEIS1 transcriptional program which is critical for leukemogenesis in histone-lysine N-methyltransferase 2A-rearranged (KMT2Ar) and in NPM1-mutated (N...

  • Communication
  • Open Access
1 Citations
2,062 Views
10 Pages

Post-Transplant Cyclophosphamide versus Anti-Thymocyte Globulin in Patients with Hematological Malignancies Treated with Allogeneic Hematopoietic Stem Cell Transplantation from Haploidentical and Matched Unrelated Donors: A Real-Life Experience

  • Bianca Serio,
  • Gabriella Storti,
  • Matteo D’Addona,
  • Lidia Santoro,
  • Camilla Frieri,
  • Danilo De Novellis,
  • Luana Marano,
  • Giovanna De Santis,
  • Roberto Guariglia and
  • Ilenia Manfra
  • + 10 authors

17 April 2024

Background: Post-transplant cyclophosphamide (PTCY) is widely used as graft versus host disease (GvHD) prophylaxis in allogeneic hematopoietic stem cell transplant (HSCT) recipients, with reported clinical benefits in patients who underwent transplan...

  • Article
  • Open Access
1 Citations
1,723 Views
14 Pages

Monitoring Humoral Response Following BNT162b2 mRNA Vaccination against SARS-CoV-2 in Hematopoietic Stem-Cell Transplantation Patients: A Single-Center Prospective Study along with a Brief Review of Current Literature

  • John V. Asimakopoulos,
  • Eleni Lalou,
  • George Seferlis,
  • Maria Malliarou,
  • Eliana Konstantinou,
  • Ioannis Drandakis,
  • Ioannis Vasilopoulos,
  • Angeliki N. Georgopoulou,
  • Anastasia Kopsaftopoulou and
  • Alexandros Machairas
  • + 14 authors

16 April 2024

Data on antibody response (AR) after vaccination against SARS-CoV2 in hematopoietic stem-cell transplantation setting (HSCT) were initially scarce, mainly due to the exclusion of such patients from approval studies. Shortly after the worldwide applic...

  • Review
  • Open Access
15 Citations
15,911 Views
16 Pages

Pathophysiology, Clinical Manifestations and Diagnosis of Immune Thrombocytopenia: Contextualization from a Historical Perspective

  • Daniel Martínez-Carballeira,
  • Ángel Bernardo,
  • Alberto Caro,
  • Inmaculada Soto and
  • Laura Gutiérrez

Immune thrombocytopenia (ITP) is an autoimmune disease characterized by an isolated decrease in the platelet count and an increased risk of bleeding. The pathogenesis is complex, affecting multiple components of the immune system and causing both per...

  • Review
  • Open Access
3 Citations
2,612 Views
11 Pages

Ophthalmic Manifestations in Patients with Blood Malignancies

  • Costanza Rossi,
  • Alessandro Buizza,
  • Giuseppe Alessio,
  • Massimiliano Borselli,
  • Andrea Taloni,
  • Adriano Carnevali,
  • Giovanna Carnovale Scalzo,
  • Andrea Lucisano,
  • Vincenzo Scorcia and
  • Giuseppe Giannaccare

28 March 2024

Ocular complications can occur in up to 90% of patients with blood malignancies. Such complications range from direct infiltration to local hemostatic imbalance and treatment-related toxicity. This narrative review is based on a systematic computeriz...

  • Case Report
  • Open Access
1,912 Views
8 Pages

Partial Splenic Embolization in a Patient with Hemophilia A and Severe Thrombocytopenia: A Case Report

  • Tomofumi Nakamura,
  • Mitsuhiro Uchiba,
  • Hirotomo Nakata,
  • Takao Mizumoto,
  • Toru Beppu and
  • Shuzo Matsushita

26 March 2024

We report a patient with hemophilia A who underwent partial splenic embolization (PSE) for severe thrombocytopenia secondary to portal hypertension-induced splenomegaly, resulting in a stable long-term quality of life. The patient was diagnosed with...

of 3

Get Alerted

Add your email address to receive forthcoming issues of this journal.

XFacebookLinkedIn
Hematol. Rep. - ISSN 2038-8330Creative Common CC BY license